Specific targeting of the deubiquitinase and E3 ligase families with engineered ubiquitin variants.

Authors:
Gorelik M; Sidhu SS.

Journal:
Bioeng Transl Med

Publication Year: 2016

DOI:
10.1002/btm2.10044

PMCID:
PMC5434665

PMID:
28580429

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Bioeng Transl Med

Abbreviation: Bioeng Transl Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Engineering, Biomedical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
4D-CT deformable image registration using unsupervised recursive cascaded full-resolution residual …
Xu L; Jiang P; Tsui T and 4 more (2023) - Transparency Score: 3/6
Activation of NR1H3 attenuates the severity of septic myocardial injury by inhibiting NLRP3 inflamm…
Deng C; Liu Q; Zhao H and 9 more (2023) - Transparency Score: 3/6
Adipose-derived stem cells enriched with therapeutic mRNA TGF-β3 and IL-10 synergistically promote …
Wang W; Chen L; Zhang Y and 5 more (2023) - Transparency Score: 4/6
Adjustable extracellular matrix rigidity tumor model for studying stiffness dependent pancreatic du…
Zhang H; Chen J; Hu X and 2 more (2023) - Transparency Score: 3/6
A drug-selectable acoustic reporter gene system for human cell ultrasound imaging.
Howells AR; Welch PJ; Kim J and 3 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"Funding Information This work was supported by the Canadian Institutes of Health Research, with an operating grant (MOP‐136956) to S.S.S. and a postdoctoral fellowship to M. G."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025